相似文献
1
Toward a COVID-19 vaccine strategy for patients with pemphigus on rituximab.
J Am Acad Dermatol. 2021 Apr;84(4):e197-e198. doi: 10.1016/j.jaad.2020.10.075. Epub 2020 Oct 29.
2
Rituximab as the treatment of pemphigus vulgaris in the COVID-19 pandemic era: A narrative review.
Dermatol Ther. 2021 Jan;34(1):e14405. doi: 10.1111/dth.14405. Epub 2020 Oct 20.
3
Can rituximab be used in the treatment of pemphigus vulgaris during the COVID-19 pandemic?
Dermatol Ther. 2021 Jan;34(1):e14647. doi: 10.1111/dth.14647. Epub 2020 Dec 15.
4
Estimating the susceptibility to SARS-CoV-2 infection with rituximab use for pemphigus vulgaris.
J Dermatolog Treat. 2022 May;33(3):1606-1607. doi: 10.1080/09546634.2020.1870648. Epub 2021 Jan 12.
5
COVID-19 severity and SARS-Cov-2 vaccine safety in pemphigus patients.
Dermatol Ther. 2022 May;35(5):e15417. doi: 10.1111/dth.15417. Epub 2022 Mar 10.
6
SARS-CoV-2 Vaccination Effectiveness in Rituximab-Treated Patients Affected by Pemphigus Vulgaris.
J Invest Dermatol. 2023 Aug;143(8):1601-1604. doi: 10.1016/j.jid.2022.12.023. Epub 2023 Jan 28.
7
Pemphigus vulgaris relapse during the coronavirus disease pandemic.
Dermatol Ther. 2022 Apr;35(4):e15354. doi: 10.1111/dth.15354. Epub 2022 Feb 12.
8
T Cells Remember SARS-CoV-2 in Rituximab-Treated Pemphigus Vulgaris.
J Invest Dermatol. 2023 Aug;143(8):1340-1341. doi: 10.1016/j.jid.2023.02.002. Epub 2023 Mar 21.
9
Rituximab for COVID-19 Vaccine-Associated Pemphigus Vulgaris.
Am J Ther. 2023;30(6):e544-e546. doi: 10.1097/MJT.0000000000001620. Epub 2023 Mar 7.
10
SARS CoV-2 vaccine AND rituximab. Comment on: "SARS CoV-2 vaccine AND rituximab, timing is probably a key for a better vaccine response" by Verhoeven Joint Bone Spine. 2021;88:105258.
Joint Bone Spine. 2022 Jan;89(1):105281. doi: 10.1016/j.jbspin.2021.105281. Epub 2021 Sep 29.
引用本文的文献
1
The challenges of the pandemic and the vaccination against covid-19 in pediatric patients with kidney disease.
J Bras Nefrol. 2023 Apr-Jun;45(2):244-251. doi: 10.1590/2175-8239-JBN-2022-0081en.
2
A systematic review on mucocutaneous presentations after COVID-19 vaccination and expert recommendations about vaccination of important immune-mediated dermatologic disorders.
Dermatol Ther. 2022 Jun;35(6):e15461. doi: 10.1111/dth.15461. Epub 2022 Apr 11.
3
Seroconversion after COVID-19 vaccination for multiple sclerosis patients on high efficacy disease modifying medications.
Mult Scler Relat Disord. 2022 Apr;60:103719. doi: 10.1016/j.msard.2022.103719. Epub 2022 Mar 3.
4
Impact of COVID-19 on autoimmune blistering diseases.
Clin Dermatol. 2021 May-Jun;39(3):359-368. doi: 10.1016/j.clindermatol.2021.01.007. Epub 2021 Feb 2.
5
Long-Term Safety of Rituximab (Risks of Viral and Opportunistic Infections).
Curr Rheumatol Rep. 2021 Jul 16;23(9):74. doi: 10.1007/s11926-021-01037-3.
6
COVID-19 vaccines: What dermatologists should know?
Dermatol Ther. 2021 Sep;34(5):e15056. doi: 10.1111/dth.15056. Epub 2021 Jul 13.
7
Case Report: Complete and Fast Recovery From Severe COVID-19 in a Pemphigus Patient Treated With Rituximab.
Front Immunol. 2021 Apr 16;12:665522. doi: 10.3389/fimmu.2021.665522. eCollection 2021.
8
How to Manage COVID-19 Vaccination in Immune-Mediated Inflammatory Diseases: An Expert Opinion by IMIDs Study Group.
Front Immunol. 2021 Apr 15;12:656362. doi: 10.3389/fimmu.2021.656362. eCollection 2021.
本文引用的文献
1
Effect of ocrelizumab on vaccine responses in patients with multiple sclerosis: The VELOCE study.
Neurology. 2020 Oct 6;95(14):e1999-e2008. doi: 10.1212/WNL.0000000000010380. Epub 2020 Jul 29.
2
Immunizations in immunocompromised patients: a guide for dermatologists.
J Dtsch Dermatol Ges. 2020 Jul;18(7):699-723. doi: 10.1111/ddg.14156.
3
COVID-19 vaccine-readiness for anti-CD20-depleting therapy in autoimmune diseases.
Clin Exp Immunol. 2020 Nov;202(2):149-161. doi: 10.1111/cei.13495. Epub 2020 Aug 1.
4
Could anti-CD20 therapy jeopardise the efficacy of a SARS-CoV-2 vaccine?
Eur J Cancer. 2020 Sep;136:4-6. doi: 10.1016/j.ejca.2020.06.017. Epub 2020 Jun 25.
5
mRNA vaccines - a new era in vaccinology.
Nat Rev Drug Discov. 2018 Apr;17(4):261-279. doi: 10.1038/nrd.2017.243. Epub 2018 Jan 12.
Zotero 插件